Found: 9
Select item for more details and to access through your institution.
The novel GIP, GLP‐1 and glucagon receptor agonist retatrutide delays gastric emptying.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2784, doi. 10.1111/dom.15167
- By:
- Publication type:
- Article
Long-Acting and Selective Oxytocin Peptide Analogs Show Antidiabetic and Antiobesity Effects in Male Mice.
- Published in:
- Journal of the Endocrine Society, 2019, v. 3, n. 7, p. 1423, doi. 10.1210/js.2019-00004
- By:
- Publication type:
- Article
Modified UCN2 peptide treatment improves skeletal muscle mass and function in mouse models of obesity‐induced insulin resistance.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2021, v. 12, n. 5, p. 1232, doi. 10.1002/jcsm.12746
- By:
- Publication type:
- Article
Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179856
- By:
- Publication type:
- Article
GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior.
- Published in:
- Diabetes, 2022, v. 71, n. 7, p. 1410, doi. 10.2337/db21-0848
- By:
- Publication type:
- Article
GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist-Induced Nausea and Emesis in Preclinical Models.
- Published in:
- 2021
- By:
- Publication type:
- journal article
679-P: The Novel GIP, GLP-1, and Glucagon Triple Receptor Agonist LY3437943 Exhibits Robust Efficacy in Preclinical Models of Obesity and Diabetes.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-679-P
- By:
- Publication type:
- Article
639-P: GIP Receptor Agonism Enhances Weight Loss from Either a Biased or an Unbiased GLP-1 Receptor Agonist in DIO Mice.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-639-P
- By:
- Publication type:
- Article
Modified UCN2 Peptide Acts as an Insulin Sensitizer in Skeletal Muscle of Obese Mice.
- Published in:
- 2019
- By:
- Publication type:
- journal article